The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SIGY · Healthcare · No moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
ABUS · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
RNLXY · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | SIGY | ABUS | TFX | RNLXY |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | — | 53 (highest) | 20 | 30 |
| Pricing power | 80 | — | 89 (highest) | 22 |
| Returns on capital | 0 | 0 | 9 (highest) | — |
| Balance-sheet safety | 28 | 55 (highest) | 0 | 55 (highest) |
| Capital allocation | 24 | 24 | 47 (highest) | 24 |
| No price data | No price data | 15% above value if growth stopped today | No price data | |
| Market cap | $48161 | $843M | $5.8B | Not reported |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2024 | FY2025 | FY2025 | FY2024 |